ENLIGHTENED POST

Explore, Engage, Enlighten

EP MONEY

India’s chip imports jump 53 percent as AI demand pushes prices higher

India imported memory chips worth $6.79 billion in the financial year ending March 2026, representing a 53 percent increase from the previous year. This sharp surge reflects a global shift in chip markets driven by the artificial intelligence boom sweeping across technology companies worldwide. Memory chips are the physical components that store data and process […]

India’s chip imports jump 53 percent as AI demand pushes prices higher Read More »

Sarvam AI Enters Unicorn Club After $234 Million Fundraise Led by HCLTech

India’s artificial intelligence ecosystem has a new unicorn. Bengaluru-based Sarvam AI has raised $234 million in the first close of its Series B funding round, taking its valuation to $1.5 billion and cementing its position as one of the country’s most prominent AI startups. The round was led by HCLTech and Bessemer Venture Partners, with

Sarvam AI Enters Unicorn Club After $234 Million Fundraise Led by HCLTech Read More »

Car insurers quietly change E20 petrol rules but keep hidden damage clauses

India’s car insurance industry is grappling with a fundamental transparency problem that affects millions of vehicle owners. Insurance companies have quietly shifted their position on E20 fuel use in older cars, but the change masks a deeper coverage problem buried in policy fine print. E20 is a petrol blend containing 20 percent ethanol, introduced by

Car insurers quietly change E20 petrol rules but keep hidden damage clauses Read More »

US fuel prices will stay high for months even after Iran deal ends war

The United States has announced a deal to end its conflict with Iran, but consumers should not expect fuel prices to drop immediately. Energy analysts warn that petrol and diesel prices will remain higher than normal for several months, even after the agreement is implemented. The reason is straightforward: the global oil market cannot adjust

US fuel prices will stay high for months even after Iran deal ends war Read More »

Indian electronics makers face component shortages from Gulf shipping crisis

Indian electronics manufacturers are facing one of their biggest supply chain disruptions in recent months as a shipping crisis in the Gulf region creates a bottleneck for essential components. Microprocessors, batteries, and other critical parts that form the backbone of smartphone, laptop, and appliance production are arriving late and at higher costs, forcing companies to

Indian electronics makers face component shortages from Gulf shipping crisis Read More »

Government rejects claim that RBI sold gold to boost revenues

The Centre has rejected a Bloomberg Economics analysis that suggested the Reserve Bank of India may have sold gold reserves to bolster the country’s foreign-currency assets. The Bloomberg Economics report estimated that the RBI likely sold around $12 billion worth of gold in the two weeks through May 22 while purchasing roughly $7.5 billion in

Government rejects claim that RBI sold gold to boost revenues Read More »

Mutual Funds stayed away from Rajesh Exports, LIC didn’t

For at least a decade, India’s domestic institutional investors largely stayed away from Rajesh Exports. Mutual funds, which held a peak stake of just 0.5% in March 2016, have since exited completely. Private insurance companies hold no meaningful exposure either. LIC took a different view. The state-owned insurer increased its stake more than fivefold, from

Mutual Funds stayed away from Rajesh Exports, LIC didn’t Read More »

Government allows price hikes for two cancer drugs facing shortages

India’s government has taken a controversial step to address severe shortages of two critical cancer drugs by approving price increases for cisplatin and carboplatin. The Centre granted in-principle approval using special powers under Para 19 of the Drugs Price Control Order, or DPCO. This move allows manufacturers to raise prices, with final numbers to be

Government allows price hikes for two cancer drugs facing shortages Read More »